Pediatrix Medical (PDX) Reports In-Line Q3; Guides
More News related to PDX
- Pediatrix Medical Name Change to MEDNAX Effective Today
- Pediatrix Medical (PDX) Acquires Tampa Bay Maternal Fetal Group Practice
- Wasserman Initiates Coverage on Pediatrix Medical Group (PDX) with a Buy
- Pediatrix Medical (PDX) Reports In-Line Q3; Guides
- Citi Maintains 'Buy' on Pediatrix Medical Group (PDX), Drops Price Target
More News related to Earnings
- Thomas Weisel Initiates Coverage on UQM Technologies (UQM) with an Overweight
- Oppenheimer Initiates Coverage on China Integrated Energy (CBEH) with an Outperform
- J.P. Morgan Initiates Coverage Movie Production, Theaters Stocks CNK & RGC
- Several Brokerage Firms Initiate Coverage on Talecris Biotherapeutics (TLCR)
- Janney Montgomery Scott Initiates Coverage on CRA International (CRAI) with a Neutral
Pediatrix Medical Group, Inc. (NYSE: PDX) reports Q3 EPS of $0.81, in-line with the consensus of $0.81. Revenues came in at $267.2 million, versus the consensus of $258.8 million.
Sees Q4 EPS of $0.77-$0.81, versus the consensus of $0.82.
Pediatrix Medical Group, Inc. provides neonatal, maternal-fetal, other pediatric subspecialty, and anesthesia physician services in the United States and Puerto Rico.
Related Categories
EarningsGuidance
Stocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
